Erythropoiesis-stimulating agents in sickle cell anaemia-Reference-Cited by-同舟云学术

Erythropoiesis-stimulating agents in sickle cell anaemia

Published:2017-07-27 Issue:4 Volume:182 Page:602-605
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Han Jin¹²³,Zhou Jifang³,Kondragunta Vinod¹,Zhang Xu¹,Molokie Robert E.¹,Gowhari Michel¹,Hassan Johara¹,Jain Shivi¹,Calip Gregory S.³^ORCID,Gordeuk Victor R.¹,Saraf Santosh L.¹^ORCID

Affiliation:

1. Division of Hematology & Oncology; Department of Medicine; Comprehensive Sickle Cell Center; University of Illinois at Chicago; Chicago IL USA

2. Department of Pharmacy Practice; College of Pharmacy; University of Illinois at Chicago; Chicago IL USA

3. Center for Pharmacoepidemiology and Pharmacoeconomic Research; University of Illinois at Chicago; Chicago IL USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14846/fullpdf

Reference10 articles.

1. Treatment of sickle cell anemia with hydroxyurea and erythropoietin;Goldberg;New England Journal of Medicine,1990

2. On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease;el-Hazmi;Acta Haematologica,1995

3. Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review;Little;Haematologica,2006

4. Identification and validation of a sickle cell disease cohort within electronic health records;Michalik;Academic Pediatric,2017

5. Erythropoietin and renal function in sickle-cell disease;Morgan;British Medical Journal (Clinical Research Ed),1982

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of sodium‐glucose cotransporter‐2 improves anaemia in mice and humans with sickle cell disease, and reduces infarct size in a murine stroke model;Journal of Cellular and Molecular Medicine;2024-09

2. Evaluation of the effect of voxelotor and darbepoetin alfa on hemoglobin levels in patients with sickle cell disease;Expert Review of Hematology;2024-05-16

3. Sickle Cell Disease in Brazil: Current Management;Hemoglobin;2024-04-25

4. Hemolysis-driven IFNα production impairs erythropoiesis by negatively regulating EPO signaling in sickle cell disease;Blood Journal;2023-12-20

5. Sickle Cell Disease and CKD: An Update;American Journal of Nephrology;2023-10-27